A recent national study published in The Journal of Hepatology has shed light on a concerning trend that close relatives of individuals with Metabolic-Associated Fatty Liver Disease (MASLD), formerly known as NAFLD, are at a significantly higher risk of developing liver cancer and experiencing advanced liver-related disorders. This study, conducted by researchers at the Karolinska Institute in Sweden, has important implications for both patients and their families. It suggests that the conventional approach to managing MASLD should be expanded to encompass not just the patients but also their family members. Furthermore, it underscores the potential benefits of early screening.
Growing concern of MASLD
